IL6 and chronic obstructive pulmonary disease: Decreased lung function is associated with increased oxidative stress and inflammation, and studies have shown that statins reduce the levels of inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) in COPD patients [26] and slow the decline in lung function [27].